Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6783) 6783
Book Chapter (67) 67
Magazine Article (16) 16
Dissertation (9) 9
Web Resource (5) 5
Book / eBook (3) 3
Newsletter (3) 3
Conference Proceeding (2) 2
Book Review (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6017) 6017
science & technology (5267) 5267
life sciences & biomedicine (5122) 5122
male (3828) 3828
female (3775) 3775
aged (3057) 3057
middle aged (2888) 2888
pneumonia (2556) 2556
infectious diseases (2438) 2438
adult (2327) 2327
community-acquired infections - epidemiology (1907) 1907
community-acquired infections - drug therapy (1859) 1859
community-acquired infections - microbiology (1815) 1815
biological and medical sciences (1789) 1789
risk factors (1768) 1768
medical sciences (1734) 1734
aged, 80 and over (1733) 1733
anti-bacterial agents - therapeutic use (1562) 1562
community-acquired pneumonia (1470) 1470
community-acquired infections - mortality (1429) 1429
general & internal medicine (1425) 1425
mortality (1414) 1414
community-acquired infections - diagnosis (1242) 1242
bacterial pneumonia (1229) 1229
retrospective studies (1217) 1217
adolescent (1135) 1135
microbiology (1124) 1124
prospective studies (1104) 1104
respiratory system (964) 964
antibiotics (960) 960
severity of illness index (957) 957
prognosis (931) 931
health aspects (897) 897
hospitalization (892) 892
treatment outcome (885) 885
medicine, general & internal (869) 869
abridged index medicus (844) 844
community-acquired infections (826) 826
research (749) 749
bacterial diseases (727) 727
pneumonia - mortality (713) 713
child (703) 703
human bacterial diseases (684) 684
hospitals (667) 667
child, preschool (664) 664
pneumonia, bacterial - drug therapy (654) 654
care and treatment (643) 643
pneumonia - drug therapy (639) 639
infant (611) 611
community-acquired infections - therapy (605) 605
internal medicine (585) 585
incidence (582) 582
epidemiology (581) 581
young adult (581) 581
pneumonia - diagnosis (575) 575
critical care medicine (556) 556
cross infection - epidemiology (539) 539
cross infection - microbiology (537) 537
analysis (534) 534
cohort studies (517) 517
infections (508) 508
pneumonia - epidemiology (495) 495
pharmacology & pharmacy (492) 492
comorbidity (474) 474
diagnosis (465) 465
immunology (464) 464
staphylococcus aureus (460) 460
patients (442) 442
hospital mortality (434) 434
pneumonia, bacterial - microbiology (433) 433
community-acquired infections - complications (430) 430
infectious disease (415) 415
general aspects (400) 400
microbial sensitivity tests (399) 399
research article (398) 398
pneumonia - therapy (393) 393
pneumology (391) 391
length of stay (386) 386
drug therapy (383) 383
pharmacology. drug treatments (379) 379
nosocomial infections (370) 370
pediatrics (370) 370
pneumonia, bacterial - diagnosis (368) 368
staphylococcal infections - microbiology (358) 358
medicine (356) 356
patient outcomes (355) 355
anti-bacterial agents - administration & dosage (349) 349
anti-bacterial agents - pharmacology (348) 348
community-acquired infections - blood (348) 348
bacteremia - microbiology (347) 347
medicine & public health (345) 345
age factors (343) 343
staphylococcal infections - epidemiology (337) 337
antibacterial agents (335) 335
pneumonia, bacterial - mortality (334) 334
sepsis (334) 334
intensive care units (333) 333
pneumonia - microbiology (333) 333
medical research (328) 328
time factors (328) 328
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6565) 6565
Spanish (186) 186
French (79) 79
Portuguese (64) 64
German (61) 61
Japanese (33) 33
Russian (28) 28
Turkish (19) 19
Chinese (18) 18
Italian (14) 14
Polish (12) 12
Korean (9) 9
Dutch (8) 8
Hungarian (6) 6
Serbian (3) 3
Croatian (2) 2
Lithuanian (2) 2
Ukrainian (2) 2
Czech (1) 1
Hebrew (1) 1
Icelandic (1) 1
Latvian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Costs of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial-Susceptible Organisms
by Matthew J. Neidell and Bevin Cohen and Yoko Furuya and Jennifer Hill and Christie Y. Jeon and Sherry Glied and Elaine L. Larson
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | Hospitalization | Health care expenditures | Bacterial infections | Incentives | Mortality | Index Medicus | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience
by Bajaj, Jasmohan S and O'Leary, Jacqueline G and Reddy, K. Rajender and Wong, Florence and Olson, Jody C and Subramanian, Ram M and Brown, Geri and Noble, Nicole A and Thacker, Leroy R and Kamath, Patrick S and NACSELD
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2012, Volume 56, Issue 6, pp. 2328 - 2335
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Other diseases. Semiology | Multivariate Analysis | Prospective Studies | Humans | Middle Aged | Cross Infection - mortality | Liver Cirrhosis - mortality | Male | Enterocolitis, Pseudomembranous - microbiology | Candidiasis - microbiology | Bacterial Infections - complications | Enterocolitis, Pseudomembranous - mortality | End Stage Liver Disease - complications | Female | Bacterial Infections - microbiology | Length of Stay | Severity of Illness Index | Community-Acquired Infections - mortality | Hospital Mortality | Liver Cirrhosis - complications | Risk Factors | Clostridium difficile | Candidiasis - mortality | Logistic Models | End Stage Liver Disease - mortality | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Organ Dysfunction Scores | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Fatalities | Infections | Liver cirrhosis | Mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
by Schuetz, Philipp and Wirz, Yannick and Sager, Ramon and Christ-Crain, Mirjam and Stolz, Daiana and Tamm, Michael and Bouadma, Lila and Luyt, Charles E and Wolff, Michel and Chastre, Jean and Tubach, Florence and Kristoffersen, Kristina B and Burkhardt, Olaf and Welte, Tobias and Schroeder, Stefan and Nobre, Vandack and Wei, Long and Bucher, Heiner C and Annane, Djillali and Reinhart, Konrad and Falsey, Ann R and Branche, Angela and Damas, Pierre and Nijsten, Maarten and de Lange, Dylan W and Deliberato, Rodrigo O and Oliveira, Carolina F and Maravić-Stojković, Vera and Verduri, Alessia and Beghé, Bianca and Cao, Bin and Shehabi, Yahya and Jensen, Jens-Ulrik S and Corti, Caspar and van Oers, Jos A H and Beishuizen, Albertus and Girbes, Armand R J and de Jong, Evelien and Briel, Matthias and Mueller, Beat
The Lancet infectious diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 95 - 107
C-REACTIVE PROTEIN | COMMUNITY-ACQUIRED PNEUMONIA | GENE-RELATED PEPTIDE | PRIMARY-CARE | EMPIRICAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | DE-ESCALATION | SEPTIC PATIENTS | TRACT INFECTIONS | SEVERE SEPSIS | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Length of Stay | Bacterial Infections - drug therapy | Humans | Middle Aged | Male | Respiratory Tract Infections - drug therapy | Respiratory Tract Infections - diagnosis | Drug-Related Side Effects and Adverse Reactions - epidemiology | Randomized Controlled Trials as Topic | Respiratory Tract Infections - mortality | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Bacterial Infections - diagnosis | Procalcitonin - blood | Anti-Bacterial Agents - administration & dosage | Bacterial Infections - mortality | Antibiotics | Lung diseases | Patient outcomes | Mortality | Analysis | Pneumonia | Intensive care | Bacterial infections | Procalcitonin | Systematic review | Infections | FDA approval | Patients | Clinical outcomes | Meta-analysis | Studies | Databases | Biomarkers | Sepsis | Bronchitis | Libraries | Viral infections | Ambulatory care | Health care | Bias | Clinical trials | Exposure | Subgroups | Side effects | Reduction | Data collection | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia
by Bassetti, M and Trecarichi, E.M and Mesini, A and Spanu, T and Giacobbe, D.R and Rossi, M and Shenone, E and Pascale, G.D and Molinari, M.P and Cauda, R and Viscoli, C and Tumbarello, M
Clinical microbiology and infection, ISSN 1198-743X, 09/2012, Volume 18, Issue 9, pp. 862 - 869
mortality | Healthcare-associated | methicillin-resistance | Staphylococcus aureus | methicillin‐resistance | Healthcare‐associated | Methicillin-resistance | Mortality | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Antibacterial agents | Bacterial sepsis | Antibiotics. Antiinfectious agents. Antiparasitic agents | Prospective Studies | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Cross Infection - mortality | Bacteremia - mortality | Male | Incidence | Methicillin-Resistant Staphylococcus aureus | Bacteremia - microbiology | Microbial Sensitivity Tests | Aged, 80 and over | Adult | Female | Staphylococcal Infections - microbiology | Methicillin Resistance | Cross Infection - epidemiology | Community-Acquired Infections - mortality | Risk Factors | Logistic Models | Treatment Outcome | Staphylococcal Infections - mortality | Staphylococcal Infections - epidemiology | Analysis of Variance | Cross Infection - microbiology | Bacteremia - epidemiology | Italy - epidemiology | Aged | Community-Acquired Infections - microbiology | Medical colleges | Corticosteroids | Long-term care of the sick | Staphylococcus aureus infections | Septic shock | Risk factors | Anti-infective agents | Cross infection | Diabetes | Nosocomial infections | Health aspects | HIV infection | Hospitalization | Older people | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Epidemiology of Methicillin-Resistant Staphylococcus aureus
by Helen W. Boucher and G. Ralph Corey
Clinical infectious diseases, ISSN 1058-4838, 6/2008, Volume 46, Issue 5, pp. S344 - S349
Infectious diseases | Antibiotics | Mortality | Virulence | Predisposing factors | Endocarditis | Methicillin resistant staphylococcus aureus | Infections | Epidemiology | Staphylococcus aureus | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Community-Acquired Infections - transmission | Geography | Community-Acquired Infections - mortality | United States - epidemiology | Community-Acquired Infections - epidemiology | Staphylococcus aureus - isolation & purification | Humans | Cross Infection - mortality | Incidence | Cross Infection - transmission | Staphylococcal Infections - transmission | Staphylococcal Infections - mortality | Staphylococcal Infections - epidemiology | Cross Infection - microbiology | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Cross Infection - epidemiology | Forecasts and trends | Cross infection | Nosocomial infections | Staphylococcus aureus infections | Distribution | Health care | Staphylococcus infections | Risk factors | Morbidity | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
by Garcia-Vidal, Carolina and Sanjuan, Gemma and Moreno-García, Estela and Puerta-Alcalde, Pedro and Garcia-Pouton, Nicole and Chumbita, Mariana and Fernandez-Pittol, Mariana and Pitart, Cristina and Inciarte, Alexy and Bodro, Marta and Morata, Laura and Ambrosioni, Juan and Grafia, Ignacio and Meira, Fernanda and Macaya, Irene and Cardozo, Celia and Casals, Climent and Tellez, Adrian and Castro, Pedro and Marco, Francesc and García, Felipe and Mensa, Josep and Martínez, José Antonio and Soriano, Alex and Rico, Verónica and Hernández-Meneses, Marta and Agüero, Daiana and Torres, Berta and González, Ana and de la Mora, Lorena and Rojas, Jhon and Linares, Laura and Fidalgo, Berta and Rodriguez, Natalia and Nicolas, David and Albiach, Laia and Muñoz, José and Almuedo, Alex and Camprubí, Daniel and Angeles Marcos, Ma and Cilloniz, Catia and Fernández, Sara and Nicolas, Jose M and Torres, Antoni and for the COVID-19 Researchers Group and COVID-19 Researchers Group
Clinical microbiology and infection, ISSN 1198-743X, 01/2021, Volume 27, Issue 1, pp. 83 - 88
COVID-19 | SARS-CoV-2 | Superinfections | Co-infections | Mortality | Sputum - microbiology | Mycoses - epidemiology | Virus Diseases - epidemiology | Coinfection | Humans | Middle Aged | Cross Infection - mortality | Mycoses - microbiology | Male | Virus Diseases - virology | Incidence | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - therapy | Blood Culture - methods | Bacterial Typing Techniques | Mycoses - therapy | Female | Retrospective Studies | COVID-19 - epidemiology | Bacterial Infections - microbiology | Cross Infection - epidemiology | Superinfection - therapy | COVID-19 - virology | Cross Infection - therapy | Virus Diseases - therapy | Hospitalization | COVID-19 - mortality | Superinfection - mortality | COVID-19 - therapy | Hospitals | SARS-CoV-2 - pathogenicity | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Superinfection - epidemiology | Survival Analysis | Aged | Virus Diseases - mortality | Mycoses - mortality | Superinfection - virology | Bacterial Infections - mortality | Community-Acquired Infections | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality
by Zahar, Jean-Ralph and Timsit, Jean-Francois and Garrouste-Orgeas, Maïté and Français, Adrien and Vesim, Aurélien and Descorps-Declere, Adrien and Dubois, Yohann and Souweine, Bertrand and Haouache, Hakim and Goldgran-Toledano, Dany and Allaouchiche, Bernard and Azoulay, Elie and Adrie, Christophe
Critical care medicine, ISSN 0090-3493, 08/2011, Volume 39, Issue 8, pp. 1886 - 1895
pathogens | severe sepsis | Outcome | site of infection | place of acquisition | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: infection, septic shock | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Multivariate Analysis | Prognosis | Prospective Studies | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Cross Infection - mortality | Male | Cause of Death | Hospital Mortality - trends | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Gram-Positive Bacteria - pathogenicity | Community-Acquired Infections - drug therapy | Shock, Septic - drug therapy | Female | Databases, Factual | Severity of Illness Index | Community-Acquired Infections - mortality | Intensive Care Units | Risk Assessment | Proportional Hazards Models | Survival Rate | Treatment Outcome | Shock, Septic - mortality | Cross Infection - drug therapy | Sepsis - mortality | Shock, Septic - microbiology | Drug Resistance, Microbial | Gram-Negative Bacteria - drug effects | Cross Infection - microbiology | Gram-Negative Bacteria - pathogenicity | Critical Care | Aged | Community-Acquired Infections - microbiology | Sepsis - microbiology | Index Medicus | Abridged Index Medicus | Cross Infection | Life Sciences | Anti-Bacterial Agents | Hospital Mortality | Gram-Negative Bacteria | Gram-Positive Bacteria | Human health and pathology | Shock, Septic | Sepsis | Intensive Care | Community-Acquired Infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
by Schuetz, Philipp and Wirz, Yannick and Sager, Ramon and Christ-Crain, Mirjam and Stolz, Daiana and Tammy, Michael and Bouadma, Lila and Luyt, Charles E and Wolff, Michel and Chastre, Jean and Tubach, Florence and Kristoffersen, Kristina B and Burkhardt, Olaf and Welte, Tobias and Schroeder, Stefan and Nobre, Vandack and Wei, Long and Bucher, Heiner C and Bhatnagar, Neera and Annane, Djillali and Reinhart, Konrad and Branche, Angela and Damas, Pierre and Nijsten, Maarten and de Lange, Dylan W and Deliberato, Roigo O and Lima, Stella S. S and Maravic-Stojkovic, Vera and Verduri, Alessia and Cao, Bin and Shehabi, Yahya and Beishuizen, Albertus and Jensen, Jens-Ulrik S and Corti, Caspar and Van Oers, Jos A and Falsey, Ann R and de Jong, Evelien and Oliveira, Carolina F and Beghe, Bianca and Briel, Matthias and Mueller, Beat
Cochrane database of systematic reviews, ISSN 1469-493X, 2017, Volume 2019, Issue 10, pp. CD007498 - CD007498
C-REACTIVE PROTEIN | COMMUNITY-ACQUIRED PNEUMONIA | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ACUTE EXACERBATIONS | HUMAN SEPTIC SHOCK | RANDOMIZED CONTROLLED-TRIAL | SERUM PROCALCITONIN | CRITICALLY-ILL PATIENTS | SEVERE SEPSIS | Respiratory infections in general | Acute Disease | Lungs & airways | Undifferentiated acute respiratory infections | Respiratory Tract Infections | Calcitonin Gene‐Related Peptide | Respiratory infections: general treatment | Cause of Death | Randomized Controlled Trials as Topic | Infectious disease | Bacterial Infections | Calcitonin | Treatment Failure | Anti‐Bacterial Agents | Protein Precursors | Child health | Respiratory infections | Biomarkers | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcitonin Gene-Related Peptide | Calcitonin - blood | Protein Precursors - blood | Bacterial Infections - drug therapy | Humans | Respiratory Tract Infections - drug therapy | Biomarkers - blood | Anti-Bacterial Agents - therapeutic use | Respiratory Tract Infections - mortality | Anti-Bacterial Agents - adverse effects | Bacterial Infections - blood | Bacterial Infections - mortality | Respiratory Tract Infections - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights